Alkylating Drug [EPC]

Alkylating Drug [EPC] was reported 243979 times

Drugs of the Alkylating Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HYPERMUTATION 136 0.9714
1 LYMPHOID TISSUE HYPOPLASIA 143 0.9346
2 THYMUS HYPOPLASIA 144 0.8276
3 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1374 0.6226
4 HUMAN BOCAVIRUS INFECTION 117 0.6190
5 CYSTITIS VIRAL 221 0.5770
6 ENGRAFTMENT SYNDROME 341 0.5770
7 VIRAL HAEMORRHAGIC CYSTITIS 406 0.5702
8 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1373 0.4962
9 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 659 0.4664
10 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 440 0.4646
11 OVARIAN FAILURE 246 0.4598
12 IDIOPATHIC PNEUMONIA SYNDROME 135 0.4530
13 ACUTE GRAFT VERSUS HOST DISEASE 2074 0.4526
14 ENGRAFT FAILURE 129 0.4495
15 B-CELL LYMPHOMA RECURRENT 244 0.4494
16 MANTLE CELL LYMPHOMA RECURRENT 194 0.4460
17 ENCEPHALITIS CYTOMEGALOVIRUS 195 0.4452
18 VENOOCCLUSIVE DISEASE 1084 0.4326
19 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 288 0.4006
20 CYTOMEGALOVIRUS INFECTION REACTIVATION 1768 0.3998
21 CONGENITAL APLASIA 123 0.3955
22 VENOOCCLUSIVE LIVER DISEASE 1939 0.3923
23 CHRONIC GRAFT VERSUS HOST DISEASE 1407 0.3893
24 HUMAN HERPESVIRUS 6 INFECTION 720 0.3805
25 GRAFT VERSUS HOST DISEASE IN SKIN 834 0.3782
26 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 343 0.3704
27 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 778 0.3653
28 CYSTITIS HAEMORRHAGIC 1426 0.3534
29 ADENOVIRUS INFECTION 970 0.3341
30 BK VIRUS INFECTION 1090 0.3229
31 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 423 0.3212
32 FOLLICULAR LYMPHOMA 281 0.3193
33 NEUROBLASTOMA 121 0.3159
34 GLIOBLASTOMA MULTIFORME 254 0.3017
35 SECONDARY IMMUNODEFICIENCY 353 0.2905
36 FEBRILE NEUTROPENIA 18970 0.2857
37 EPSTEIN-BARR VIRAEMIA 316 0.2849
38 HUMAN POLYOMAVIRUS INFECTION 150 0.2825
39 GRAFT VERSUS HOST DISEASE IN LIVER 200 0.2793
40 NEUTROPENIC INFECTION 264 0.2759
41 HEPATITIS B REACTIVATION 873 0.2748
42 GRAFT VERSUS HOST DISEASE 1968 0.2734
43 DISSEMINATED ASPERGILLOSIS 129 0.2733
44 FEBRILE BONE MARROW APLASIA 1143 0.2687
45 MENINGITIS TUBERCULOUS 149 0.2665
46 CYTOMEGALOVIRUS CHORIORETINITIS 520 0.2664
47 MALIGNANT TRANSFORMATION 117 0.2606
48 B-CELL TYPE ACUTE LEUKAEMIA 182 0.2480
49 DIFFUSE LARGE B-CELL LYMPHOMA 1899 0.2462
50 GLIOMA 157 0.2442
51 JC VIRUS INFECTION 389 0.2431
52 HYPOGAMMAGLOBULINAEMIA 1562 0.2375
53 CENTRAL NERVOUS SYSTEM LYMPHOMA 325 0.2357
54 PNEUMONIA CYTOMEGALOVIRAL 456 0.2346
55 PREMATURE MENOPAUSE 215 0.2327
56 HAEMATOTOXICITY 2213 0.2327
57 CYTOMEGALOVIRUS VIRAEMIA 1022 0.2295
58 PSEUDOMONAL SEPSIS 401 0.2288
59 PARAINFLUENZAE VIRUS INFECTION 347 0.2278
60 APLASIA 434 0.2214
61 PLASMA CELL MYELOMA REFRACTORY 296 0.2212
62 NEUTROPENIC SEPSIS 1573 0.2200
63 NEUTROPENIC COLITIS 455 0.2198
64 ACUTE PROMYELOCYTIC LEUKAEMIA 223 0.2169
65 PULMONARY VENO-OCCLUSIVE DISEASE 149 0.2129
66 GLIOBLASTOMA 361 0.2114
67 ENTEROCOCCAL BACTERAEMIA 223 0.2104
68 ENCEPHALITIS VIRAL 256 0.2102
69 MUCOSAL INFLAMMATION 5488 0.2094
70 KLEBSIELLA BACTERAEMIA 198 0.2084
71 TUMOUR PSEUDOPROGRESSION 228 0.2082
72 SYSTEMIC MYCOSIS 243 0.2080
73 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 123 0.2074
74 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 365 0.2063
75 TRANSPLANT FAILURE 505 0.2058
76 VIRAEMIA 281 0.2027
77 CYTOKINE RELEASE SYNDROME 4063 0.2023
78 MYELODYSPLASTIC SYNDROME 2907 0.2008
79 ASPERGILLUS INFECTION 1310 0.1994
80 KLEBSIELLA SEPSIS 224 0.1988
81 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 513 0.1986
82 FUSARIUM INFECTION 139 0.1986
83 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1004 0.1971
84 SECOND PRIMARY MALIGNANCY 1623 0.1949
85 CEREBRAL TOXOPLASMOSIS 180 0.1927
86 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 134 0.1923
87 PNEUMOCYSTIS JIROVECI PNEUMONIA 425 0.1906
88 INFECTION REACTIVATION 218 0.1904
89 CEREBRAL ASPERGILLOSIS 116 0.1886
90 ACUTE MYELOID LEUKAEMIA 2921 0.1872
91 STEM CELL TRANSPLANT 455 0.1819
92 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 168 0.1816
93 PSEUDOMONAL BACTERAEMIA 155 0.1815
94 CYTOPENIA 2221 0.1812
95 MYCOBACTERIUM CHELONAE INFECTION 133 0.1800
96 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1066 0.1798
97 CYTOMEGALOVIRUS INFECTION 2980 0.1791
98 EPSTEIN-BARR VIRUS INFECTION 1114 0.1781
99 ACUTE MYELOID LEUKAEMIA RECURRENT 379 0.1764
100 TOXOPLASMOSIS 190 0.1759
101 LEUKAEMIA RECURRENT 294 0.1738
102 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1433 0.1736
103 TUMOUR LYSIS SYNDROME 1499 0.1702
104 CARDIOTOXICITY 1518 0.1700
105 PERIPHERAL MOTOR NEUROPATHY 238 0.1698
106 BRONCHOPULMONARY ASPERGILLOSIS 1301 0.1676
107 SYSTEMIC CANDIDA 411 0.1635
108 DIFFUSE ALVEOLAR DAMAGE 188 0.1635
109 PNEUMOCYSTIS JIROVECII INFECTION 195 0.1632
110 STREPTOCOCCAL BACTERAEMIA 177 0.1627
111 BACTERIAL SEPSIS 525 0.1610
112 POLYOMAVIRUS VIRAEMIA 169 0.1591
113 OBLITERATIVE BRONCHIOLITIS 207 0.1577
114 BONE MARROW TOXICITY 185 0.1561
115 HEPATITIS B 930 0.1542
116 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 129 0.1530
117 VARICELLA ZOSTER VIRUS INFECTION 317 0.1528
118 NEOPLASM RECURRENCE 518 0.1526
119 ESCHERICHIA BACTERAEMIA 359 0.1526
120 ENTEROCOCCAL SEPSIS 123 0.1519
121 CANDIDA SEPSIS 136 0.1516
122 ACUTE LYMPHOCYTIC LEUKAEMIA 428 0.1510
123 ENTEROBACTER INFECTION 254 0.1510
124 APLASTIC ANAEMIA 789 0.1509
125 ANAEMIA HAEMOLYTIC AUTOIMMUNE 122 0.1473
126 PNEUMOCYSTIS JIROVECII PNEUMONIA 1472 0.1465
127 MYELOSUPPRESSION 5266 0.1461
128 BONE MARROW FAILURE 2954 0.1452
129 STENOTROPHOMONAS INFECTION 197 0.1452
130 MUCORMYCOSIS 368 0.1415
131 CYTOMEGALOVIRUS TEST POSITIVE 252 0.1413
132 PNEUMONIA FUNGAL 549 0.1390
133 CAPILLARY LEAK SYNDROME 287 0.1387
134 ENTEROCOCCAL INFECTION 660 0.1364
135 GRANULOCYTE COUNT DECREASED 253 0.1363
136 THROMBOTIC MICROANGIOPATHY 1323 0.1356
137 FUNGAEMIA 213 0.1352
138 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1292 0.1352
139 ESCHERICHIA SEPSIS 392 0.1351
140 ASPERGILLOSIS 176 0.1347
141 LYMPHOPENIA 1849 0.1306
142 THERAPY PARTIAL RESPONDER 2039 0.1306
143 KLEBSIELLA INFECTION 658 0.1300
144 STAPHYLOCOCCAL BACTERAEMIA 553 0.1271
145 FEBRILE INFECTION 145 0.1232
146 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 923 0.1229
147 MICROANGIOPATHY 115 0.1223
148 MANTLE CELL LYMPHOMA 186 0.1221
149 HYPOFIBRINOGENAEMIA 119 0.1200
150 TUMOUR NECROSIS 126 0.1192
151 LUPUS NEPHRITIS 223 0.1191
152 STRONGYLOIDIASIS 192 0.1187
153 PERIPHERAL SENSORY NEUROPATHY 689 0.1178
154 DILATED CARDIOMYOPATHY 119 0.1177
155 GASTROINTESTINAL TOXICITY 562 0.1169
156 HISTIOCYTOSIS HAEMATOPHAGIC 346 0.1164
157 SUBCLAVIAN VEIN THROMBOSIS 132 0.1159
158 LEUKOENCEPHALOPATHY 430 0.1153
159 GENE MUTATION 228 0.1151
160 STAPHYLOCOCCAL SEPSIS 567 0.1147
161 BLOOD CULTURE POSITIVE 342 0.1141
162 CYTOGENETIC ABNORMALITY 128 0.1134
163 HEPATITIS E 178 0.1127
164 RHINOVIRUS INFECTION 438 0.1124
165 PLASMACYTOMA 209 0.1122
166 PNEUMONIA KLEBSIELLA 206 0.1120
167 T-CELL LYMPHOMA 128 0.1117
168 MYELOPATHY 210 0.1105
169 CYTOMEGALOVIRUS COLITIS 253 0.1099
170 BACTERAEMIA 1305 0.1098
171 PANCYTOPENIA 6116 0.1093
172 ACQUIRED GENE MUTATION 141 0.1076
173 BRAIN ABSCESS 272 0.1074
174 NEUROTOXICITY 1856 0.1058
175 PNEUMOMEDIASTINUM 191 0.1056
176 NEUTROPENIA 14289 0.1050
177 PLASMA CELL MYELOMA RECURRENT 341 0.1049
178 PNEUMATOSIS INTESTINALIS 299 0.1047
179 CLOSTRIDIUM DIFFICILE COLITIS 1109 0.1045
180 HERPES SIMPLEX 668 0.1027
181 SOFT TISSUE INFECTION 187 0.1021
182 AUTOIMMUNE HAEMOLYTIC ANAEMIA 349 0.1017
183 PULMONARY TOXICITY 717 0.1013
184 B-CELL LYMPHOMA 344 0.1012
185 B-LYMPHOCYTE COUNT DECREASED 136 0.0999
186 LEFT VENTRICULAR DYSFUNCTION 665 0.0992
187 DISEASE PROGRESSION 11684 0.0986
188 OTOTOXICITY 179 0.0967
189 CLOSTRIDIUM COLITIS 117 0.0964
190 NOCARDIOSIS 241 0.0941
191 FANCONI SYNDROME 132 0.0933
192 LYMPHOPROLIFERATIVE DISORDER 274 0.0932
193 PLATELET TRANSFUSION 120 0.0932
194 PERIPHERAL SENSORIMOTOR NEUROPATHY 117 0.0931
195 NEUTROPHIL COUNT DECREASED 3790 0.0929
196 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 115 0.0923
197 THROMBOCYTOPENIA 10306 0.0921
198 PSEUDOMONAS INFECTION 780 0.0909
199 SEPTIC SHOCK 3948 0.0906
200 STEROID DIABETES 136 0.0906
201 GASTROENTERITIS NOROVIRUS 117 0.0880
202 NEUTROPHIL COUNT ABNORMAL 247 0.0873
203 MENINGITIS CRYPTOCOCCAL 152 0.0869
204 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2457 0.0867
205 METASTASES TO MENINGES 195 0.0857
206 NEPHROPATHY TOXIC 932 0.0829
207 JUGULAR VEIN THROMBOSIS 147 0.0825
208 LEUKOPENIA 4128 0.0824
209 OSTEOLYSIS 167 0.0816
210 PNEUMONIA PSEUDOMONAL 123 0.0801
211 VENTRICULAR HYPOKINESIA 257 0.0799
212 BLOOD LACTATE DEHYDROGENASE INCREASED 1267 0.0799
213 POLYNEUROPATHY 943 0.0787
214 NEUROLOGICAL DECOMPENSATION 182 0.0786
215 CARDIAC DYSFUNCTION 291 0.0781
216 SKIN TOXICITY 441 0.0780
217 HYPOALBUMINAEMIA 605 0.0777
218 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 182 0.0776
219 CHRONIC LYMPHOCYTIC LEUKAEMIA 366 0.0771
220 PULMONARY ALVEOLAR HAEMORRHAGE 432 0.0769
221 AGRANULOCYTOSIS 1422 0.0764
222 VENOUS THROMBOSIS 293 0.0746
223 ORGANISING PNEUMONIA 369 0.0744
224 BONE MARROW TRANSPLANT 141 0.0743
225 LUNG CONSOLIDATION 208 0.0743
226 TRANSPLANT DYSFUNCTION 132 0.0739
227 ACUTE RESPIRATORY DISTRESS SYNDROME 1301 0.0735
228 OPPORTUNISTIC INFECTION 136 0.0735
229 OESOPHAGEAL CANDIDIASIS 293 0.0735
230 EJECTION FRACTION DECREASED 1138 0.0732
231 BONE MARROW DISORDER 221 0.0731
232 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 194 0.0729
233 DEVICE RELATED SEPSIS 146 0.0725
234 RECURRENT CANCER 295 0.0723
235 LUNG INFILTRATION 637 0.0720
236 MULTIPLE-DRUG RESISTANCE 223 0.0718
237 VENA CAVA THROMBOSIS 119 0.0716
238 HEPATOSPLENOMEGALY 183 0.0712
239 LYMPHOCYTE COUNT DECREASED 1260 0.0712
240 ESCHERICHIA INFECTION 584 0.0709
241 HYPOPROTEINAEMIA 133 0.0700
242 BREAST CANCER RECURRENT 220 0.0696
243 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 266 0.0696
244 CARDIOMYOPATHY 1022 0.0691
245 PARAPARESIS 122 0.0684
246 METASTASIS 488 0.0683
247 NEOPLASM PROGRESSION 2350 0.0675
248 PLASMA CELL MYELOMA 2630 0.0673
249 AMYLOIDOSIS 116 0.0672
250 HYPERBILIRUBINAEMIA 696 0.0671
251 SEPSIS 7492 0.0671
252 ENCEPHALITIS 459 0.0663
253 ENCEPHALOPATHY 1626 0.0661
254 PULMONARY HAEMORRHAGE 507 0.0648
255 RENAL TUBULAR DISORDER 181 0.0643
256 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 159 0.0643
257 PNEUMONIA VIRAL 205 0.0642
258 BLOOD IMMUNOGLOBULIN G DECREASED 159 0.0641
259 CONGESTIVE CARDIOMYOPATHY 267 0.0640
260 BACTERIAL INFECTION 1189 0.0637
261 EMPYEMA 126 0.0633
262 LYMPHOCYTOSIS 136 0.0631
263 VENTRICULAR DYSFUNCTION 162 0.0624
264 METASTATIC MALIGNANT MELANOMA 143 0.0622
265 DIABETES INSIPIDUS 149 0.0618
266 HEPATOTOXICITY 1359 0.0610
267 LYMPHADENOPATHY MEDIASTINAL 116 0.0605
268 PNEUMONIA STAPHYLOCOCCAL 119 0.0603
269 HYPERTRANSAMINASAEMIA 418 0.0600
270 METASTASES TO LUNG 690 0.0597
271 METASTASES TO LYMPH NODES 403 0.0597
272 ENTERITIS 376 0.0587
273 STAPHYLOCOCCUS TEST POSITIVE 123 0.0583
274 GROWTH RETARDATION 171 0.0580
275 PNEUMONITIS 1575 0.0578
276 CUSHINGOID 184 0.0573
277 INVASIVE DUCTAL BREAST CARCINOMA 155 0.0570
278 LYMPHOMA 875 0.0566
279 HYPOPHOSPHATAEMIA 417 0.0564
280 GUILLAIN-BARRE SYNDROME 271 0.0560
281 OLIGOHYDRAMNIOS 186 0.0557
282 COVID-19 PNEUMONIA 655 0.0554
283 CLOSTRIDIAL INFECTION 187 0.0552
284 ENTEROCOLITIS 319 0.0552
285 GRANULOCYTOPENIA 311 0.0545
286 RESPIRATORY FAILURE 3974 0.0544
287 BRAIN OEDEMA 687 0.0543
288 HAEMOLYTIC URAEMIC SYNDROME 125 0.0539
289 CANDIDA INFECTION 902 0.0534
290 PNEUMONIA BACTERIAL 489 0.0532
291 BRAIN HERNIATION 158 0.0528
292 IMMUNE THROMBOCYTOPENIA 240 0.0524
293 CANDIDIASIS 210 0.0523
294 METASTASES TO PERITONEUM 132 0.0522
295 CLOSTRIDIUM TEST POSITIVE 115 0.0521
296 ILEUS PARALYTIC 232 0.0519
297 EMBOLISM 430 0.0517
298 EMBOLISM VENOUS 157 0.0517
299 HYPERURICAEMIA 212 0.0515
300 HYDROCEPHALUS 281 0.0515
301 TUMOUR HAEMORRHAGE 147 0.0515
302 PSYCHOLOGICAL TRAUMA 437 0.0506
303 LEFT VENTRICULAR FAILURE 174 0.0505
304 MULTI-ORGAN FAILURE 869 0.0502
305 APLASIA PURE RED CELL 172 0.0499
306 ESCHERICHIA URINARY TRACT INFECTION 211 0.0496
307 METASTASES TO LIVER 871 0.0495
308 DISSEMINATED INTRAVASCULAR COAGULATION 693 0.0492
309 HYPERTRIGLYCERIDAEMIA 287 0.0490
310 WHITE BLOOD CELL COUNT DECREASED 5312 0.0490
311 PORTAL HYPERTENSION 149 0.0483
312 MALIGNANT NEOPLASM PROGRESSION 4940 0.0482
313 DISEASE RECURRENCE 2289 0.0481
314 SUSPECTED OFF LABEL USE 217 0.0480
315 ATELECTASIS 462 0.0478
316 DRUG RESISTANCE 1224 0.0476
317 DIASTOLIC DYSFUNCTION 147 0.0476
318 BONE LESION 171 0.0474
319 HYPERPYREXIA 200 0.0472
320 LUNG OPACITY 124 0.0470
321 METASTASES TO BONE 772 0.0470
322 DEVICE RELATED INFECTION 722 0.0469
323 FOETAL GROWTH RESTRICTION 285 0.0468
324 THROMBOTIC THROMBOCYTOPENIC PURPURA 165 0.0468
325 METASTASES TO CENTRAL NERVOUS SYSTEM 604 0.0468
326 GASTROINTESTINAL NECROSIS 135 0.0463
327 NECROSIS 255 0.0458
328 ACUTE HEPATIC FAILURE 626 0.0458
329 SQUAMOUS CELL CARCINOMA OF SKIN 276 0.0457
330 IMMUNOSUPPRESSION 403 0.0456
331 ACUTE PULMONARY OEDEMA 256 0.0456
332 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 466 0.0453
333 NEPHROTIC SYNDROME 311 0.0453
334 INTERSTITIAL LUNG DISEASE 2187 0.0451
335 ANAEMIA 8594 0.0450
336 METASTASES TO SPINE 150 0.0446
337 NEUROPATHY PERIPHERAL 4206 0.0442
338 EXTRAVASATION 181 0.0440
339 PARAPLEGIA 127 0.0440
340 HYPOXIA 1521 0.0431
341 PLATELET COUNT DECREASED 4599 0.0431
342 INFECTION 6245 0.0431
343 TOXIC ENCEPHALOPATHY 217 0.0428
344 VASCULAR DEVICE INFECTION 194 0.0427
345 CACHEXIA 219 0.0425
346 HEPATIC LESION 184 0.0425
347 NECROTISING FASCIITIS 150 0.0425
348 BREAST CANCER METASTATIC 455 0.0423
349 HEPATIC NECROSIS 159 0.0422
350 HEPATIC FAILURE 1272 0.0421
351 RESPIRATORY SYMPTOM 119 0.0418
352 INTESTINAL PERFORATION 468 0.0417
353 CHRONIC SINUSITIS 156 0.0415
354 SPLENOMEGALY 486 0.0414
355 ASCITES 1219 0.0414
356 TRANSAMINASES INCREASED 919 0.0413
357 LIVER ABSCESS 134 0.0413
358 LUNG ADENOCARCINOMA 124 0.0412
359 STAPHYLOCOCCAL INFECTION 1345 0.0407
360 NEUROLOGICAL SYMPTOM 233 0.0407
361 THERAPY NON-RESPONDER 1828 0.0406
362 WHITE BLOOD CELL COUNT ABNORMAL 258 0.0404
363 LUNG INFECTION 625 0.0402
364 PLEURAL EFFUSION 2431 0.0399
365 CARDIAC FAILURE ACUTE 266 0.0399
366 CHRONIC MYELOID LEUKAEMIA 184 0.0398
367 FIBROSIS 122 0.0396
368 LYMPHADENOPATHY 1403 0.0396
369 PERICARDIAL EFFUSION 916 0.0396
370 BLOOD BILIRUBIN INCREASED 1067 0.0395
371 HEPATIC FUNCTION ABNORMAL 1471 0.0394
372 PRODUCT USE IN UNAPPROVED INDICATION 9754 0.0393
373 RESPIRATORY SYNCYTIAL VIRUS INFECTION 339 0.0389
374 SERUM FERRITIN INCREASED 204 0.0386
375 HYPERVOLAEMIA 191 0.0386
376 OESOPHAGITIS 417 0.0381
377 RESPIRATORY DISTRESS 1050 0.0380
378 HERPES VIRUS INFECTION 219 0.0380
379 HAEMOGLOBIN ABNORMAL 243 0.0377
380 DYSAESTHESIA 115 0.0375
381 HAIR DISORDER 308 0.0373
382 STOMATITIS 2265 0.0373
383 HYPOKALAEMIA 1723 0.0373
384 HEPATOMEGALY 364 0.0370
385 GENERALISED OEDEMA 457 0.0369
386 THROMBOPHLEBITIS 129 0.0368
387 ARTHRITIS BACTERIAL 150 0.0365
388 MENINGITIS 242 0.0362
389 ILEUS 449 0.0361
390 TRANSPLANT REJECTION 287 0.0358
391 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 832 0.0357
392 ELECTROLYTE IMBALANCE 412 0.0354
393 ACUTE RESPIRATORY FAILURE 676 0.0351
394 PYREXIA 12159 0.0351
395 PULMONARY TUBERCULOSIS 150 0.0351
396 HAEMOLYTIC ANAEMIA 314 0.0350
397 ENDOCARDITIS 179 0.0349
398 CARDIAC TAMPONADE 165 0.0347
399 MYOCARDITIS 394 0.0343
400 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1883 0.0343
401 HYDRONEPHROSIS 256 0.0342
402 CARDIOPULMONARY FAILURE 133 0.0341
403 SQUAMOUS CELL CARCINOMA 320 0.0340
404 INTRACRANIAL PRESSURE INCREASED 189 0.0339
405 ORAL CANDIDIASIS 446 0.0338
406 CLOSTRIDIUM DIFFICILE INFECTION 739 0.0338
407 COLITIS 1278 0.0337
408 GASTROINTESTINAL PERFORATION 140 0.0336
409 PROTEINURIA 638 0.0335
410 PNEUMOTHORAX 531 0.0335
411 ADRENAL INSUFFICIENCY 406 0.0334
412 HAEMORRHAGE INTRACRANIAL 500 0.0334
413 FUNGAL INFECTION 1114 0.0334
414 ALANINE AMINOTRANSFERASE INCREASED 2045 0.0333
415 DRUG TOXICITY 452 0.0331
416 NEOPLASM 381 0.0331
417 HEPATIC CYTOLYSIS 421 0.0330
418 PERFORMANCE STATUS DECREASED 154 0.0330
419 HAEMATOCRIT DECREASED 654 0.0329
420 HAEMOLYSIS 252 0.0326
421 HEMIPARESIS 552 0.0326
422 SINUS TACHYCARDIA 457 0.0322
423 C-REACTIVE PROTEIN INCREASED 1164 0.0320
424 LUNG NEOPLASM 136 0.0318
425 LARGE INTESTINE PERFORATION 221 0.0318
426 HAEMODYNAMIC INSTABILITY 242 0.0317
427 PATHOLOGICAL FRACTURE 160 0.0315
428 TACHYPNOEA 428 0.0314
429 COAGULOPATHY 524 0.0314
430 UROSEPSIS 289 0.0313
431 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 156 0.0313
432 ASPARTATE AMINOTRANSFERASE INCREASED 1661 0.0312
433 HYPOCALCAEMIA 591 0.0312
434 MALNUTRITION 349 0.0312
435 STREPTOCOCCAL INFECTION 173 0.0311
436 CARDIAC FAILURE 2489 0.0310
437 ABDOMINAL ABSCESS 137 0.0310
438 MADAROSIS 358 0.0308
439 SKIN NECROSIS 160 0.0308
440 METASTATIC NEOPLASM 133 0.0308
441 FAILURE TO THRIVE 159 0.0306
442 HAIR COLOUR CHANGES 379 0.0304
443 HYPERNATRAEMIA 151 0.0303
444 RESPIRATORY TRACT INFECTION 784 0.0301
445 MENINGITIS ASEPTIC 134 0.0298
446 METABOLIC DISORDER 173 0.0298
447 MYOSITIS 267 0.0297
448 CARDIAC FAILURE CHRONIC 126 0.0295
449 HYPERCALCAEMIA 365 0.0295
450 ERYSIPELAS 148 0.0294
451 SKIN INFECTION 330 0.0294
452 BLOOD DISORDER 235 0.0293
453 CHOLESTASIS 563 0.0293
454 CEREBRAL ISCHAEMIA 150 0.0291
455 RED CELL DISTRIBUTION WIDTH INCREASED 121 0.0291
456 PROCTALGIA 187 0.0291
457 VASCULITIS 338 0.0290
458 OLIGURIA 180 0.0290
459 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 176 0.0289
460 GAMMA-GLUTAMYLTRANSFERASE INCREASED 638 0.0288
461 PARTIAL SEIZURES 150 0.0286
462 PAPILLOEDEMA 129 0.0285
463 ODYNOPHAGIA 170 0.0285
464 LEUKOCYTOSIS 513 0.0283
465 HYPOMAGNESAEMIA 391 0.0281
466 HYPERGLYCAEMIA 1023 0.0280
467 SARCOIDOSIS 133 0.0280
468 MENTAL STATUS CHANGES 776 0.0279
469 RETINAL HAEMORRHAGE 199 0.0279
470 TROPONIN INCREASED 212 0.0278
471 GASTROINTESTINAL INFLAMMATION 218 0.0278
472 INFLAMMATORY MARKER INCREASED 137 0.0276
473 ABDOMINAL TENDERNESS 137 0.0276
474 PYELONEPHRITIS 238 0.0274
475 LEUKAEMIA 259 0.0274
476 HAIR TEXTURE ABNORMAL 367 0.0274
477 MULTIPLE MYELOMA 127 0.0272
478 BLOOD ALBUMIN DECREASED 216 0.0272
479 ATAXIA 321 0.0270
480 PATHOGEN RESISTANCE 245 0.0269
481 HAEMATURIA 918 0.0268
482 NEUTROPHIL COUNT INCREASED 274 0.0267
483 MITRAL VALVE INCOMPETENCE 302 0.0267
484 DEEP VEIN THROMBOSIS 1727 0.0266
485 BRONCHIECTASIS 179 0.0265
486 LOW BIRTH WEIGHT BABY 210 0.0264
487 DRUG-INDUCED LIVER INJURY 825 0.0263
488 PLATELET COUNT ABNORMAL 158 0.0261
489 OFF LABEL USE 22823 0.0260
490 HYPONATRAEMIA 1467 0.0260
491 PNEUMONIA 8384 0.0259
492 PULMONARY EMBOLISM 2445 0.0257
493 CARDIOGENIC SHOCK 367 0.0256
494 STRESS CARDIOMYOPATHY 148 0.0254
495 SHOCK HAEMORRHAGIC 206 0.0253
496 BASAL CELL CARCINOMA 394 0.0252
497 MYOPATHY 218 0.0252
498 HAEMOGLOBIN DECREASED 2586 0.0252
499 STATUS EPILEPTICUS 284 0.0251
500 HEPATIC ENCEPHALOPATHY 234 0.0251
501 ACUTE KIDNEY INJURY 3830 0.0250
502 ANGIOPATHY 140 0.0250
503 SMALL INTESTINAL OBSTRUCTION 307 0.0249
504 PULMONARY FIBROSIS 476 0.0248
505 GASTROINTESTINAL INFECTION 222 0.0247
506 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 125 0.0247
507 LIVER INJURY 605 0.0246
508 HERPES ZOSTER 1415 0.0246
509 RALES 143 0.0246
510 ATRIAL FLUTTER 196 0.0245
511 OSTEONECROSIS 806 0.0245
512 PETECHIAE 255 0.0244
513 HYPOVOLAEMIC SHOCK 117 0.0244
514 HEPATITIS 620 0.0242
515 TOXIC EPIDERMAL NECROLYSIS 364 0.0239
516 BLOOD LACTIC ACID INCREASED 126 0.0239
517 ORAL DISORDER 175 0.0238
518 NO THERAPEUTIC RESPONSE 290 0.0238
519 CHOLECYSTITIS 283 0.0237
520 ANAL ABSCESS 128 0.0237
521 PULMONARY HYPERTENSION 494 0.0237
522 RENAL CELL CARCINOMA 116 0.0237
523 HEPATOCELLULAR INJURY 336 0.0237
524 HOSPICE CARE 234 0.0237
525 PREMATURE BABY 710 0.0236
526 FACIAL PARALYSIS 200 0.0234
527 HYPOVOLAEMIA 137 0.0234
528 HEPATITIS CHOLESTATIC 141 0.0234
529 VIRAL INFECTION 770 0.0231
530 PULMONARY ARTERIAL HYPERTENSION 334 0.0230
531 BLOOD ALKALINE PHOSPHATASE INCREASED 571 0.0230
532 CHOLECYSTITIS ACUTE 130 0.0229
533 INTENTIONAL PRODUCT USE ISSUE 2008 0.0229
534 HAEMODIALYSIS 192 0.0228
535 NERVOUS SYSTEM DISORDER 711 0.0228
536 APHASIA 684 0.0226
537 RENAL TUBULAR NECROSIS 222 0.0226
538 PULMONARY MASS 336 0.0225
539 ACUTE CORONARY SYNDROME 186 0.0224
540 TRICUSPID VALVE INCOMPETENCE 177 0.0223
541 HEMIPLEGIA 185 0.0222
542 TOXIC SKIN ERUPTION 219 0.0217
543 ATRIAL FIBRILLATION 2117 0.0217
544 SUBDURAL HAEMATOMA 311 0.0217
545 RENAL IMPAIRMENT 1819 0.0216
546 APPENDICITIS 202 0.0216
547 CELLULITIS 1083 0.0215
548 DERMATITIS BULLOUS 155 0.0214
549 GASTROENTERITIS 311 0.0213
550 MOUTH ULCERATION 448 0.0212
551 BRAIN NEOPLASM 195 0.0212
552 CORONAVIRUS INFECTION 139 0.0210
553 ACIDOSIS 159 0.0208
554 BODY TEMPERATURE INCREASED 423 0.0207
555 TRANSFUSION 217 0.0207
556 LYMPHOEDEMA 142 0.0205
557 TREATMENT FAILURE 1697 0.0205
558 SUPRAVENTRICULAR TACHYCARDIA 196 0.0205
559 RENAL FAILURE 2718 0.0204
560 TUBULOINTERSTITIAL NEPHRITIS 383 0.0204
561 SKIN HYPERPIGMENTATION 175 0.0203
562 PULMONARY OEDEMA 908 0.0203
563 RASH MACULO-PAPULAR 451 0.0203
564 HYPOPHAGIA 518 0.0202
565 PURPURA 179 0.0202
566 LIPASE INCREASED 155 0.0202
567 HEPATIC STEATOSIS 375 0.0201
568 SUBARACHNOID HAEMORRHAGE 205 0.0201
569 END STAGE RENAL DISEASE 366 0.0200
570 SKIN MASS 133 0.0199
571 PROTHROMBIN TIME PROLONGED 119 0.0199
572 MASS 277 0.0198
573 PREMATURE DELIVERY 315 0.0198
574 MALIGNANT MELANOMA 264 0.0197
575 SUDDEN DEATH 208 0.0196
576 HYPERTHERMIA 150 0.0196
577 RIGHT VENTRICULAR FAILURE 137 0.0195
578 LUNG DISORDER 958 0.0195
579 SKIN LESION 536 0.0195
580 IMMUNODEFICIENCY 290 0.0194
581 BLOOD CREATININE INCREASED 1265 0.0194
582 GENERAL PHYSICAL HEALTH DETERIORATION 2211 0.0191
583 CEREBRAL HAEMORRHAGE 684 0.0191
584 PANCREATITIS ACUTE 427 0.0190
585 ANURIA 162 0.0188
586 TACHYCARDIA 1671 0.0188
587 BONE PAIN 1101 0.0188
588 URINE OUTPUT DECREASED 164 0.0187
589 SHOCK 430 0.0187
590 GENERALISED TONIC-CLONIC SEIZURE 309 0.0187
591 RENAL FAILURE ACUTE 789 0.0186
592 CARDIOMEGALY 222 0.0180
593 HYPOTENSION 3606 0.0180
594 HYPOTHYROIDISM 572 0.0179
595 HEPATITIS ACUTE 115 0.0177
596 CIRCULATORY COLLAPSE 295 0.0173
597 ANOREXIA 223 0.0173
598 GRAND MAL CONVULSION 159 0.0172
599 UPPER RESPIRATORY TRACT INFECTION 792 0.0171
600 DECUBITUS ULCER 139 0.0170
601 TOXICITY TO VARIOUS AGENTS 2875 0.0170
602 INFUSION RELATED REACTION 1128 0.0170
603 OEDEMA 914 0.0168
604 ECCHYMOSIS 115 0.0168
605 EOSINOPHIL COUNT INCREASED 139 0.0167
606 GASTROINTESTINAL DISORDER 1484 0.0165
607 WHITE BLOOD CELL COUNT INCREASED 633 0.0165
608 LIVER DISORDER 731 0.0165
609 ORAL HERPES 321 0.0164
610 RENAL CYST 130 0.0164
611 ABSCESS 261 0.0163
612 JAUNDICE 440 0.0163
613 UPPER GASTROINTESTINAL HAEMORRHAGE 275 0.0163
614 PNEUMONIA ASPIRATION 407 0.0163
615 CEREBRAL INFARCTION 398 0.0163
616 BLOOD UREA INCREASED 272 0.0162
617 COVID-19 2845 0.0162
618 SENSORY LOSS 128 0.0159
619 RED BLOOD CELL COUNT DECREASED 454 0.0159
620 CHILLS 1861 0.0159
621 ALTERED STATE OF CONSCIOUSNESS 343 0.0158
622 CONVULSION 904 0.0158
623 OSTEONECROSIS OF JAW 390 0.0157
624 SEIZURE 1811 0.0157
625 OBSTRUCTIVE AIRWAYS DISORDER 173 0.0155
626 TENDERNESS 162 0.0155
627 NAIL DISORDER 136 0.0155
628 VOMITING 7260 0.0154
629 RESPIRATORY DISORDER 460 0.0154
630 PERICARDITIS 258 0.0153
631 OSTEOMYELITIS 278 0.0153
632 CENTRAL NERVOUS SYSTEM LESION 210 0.0153
633 DIARRHOEA HAEMORRHAGIC 142 0.0152
634 FULL BLOOD COUNT DECREASED 306 0.0152
635 GASTROINTESTINAL HAEMORRHAGE 1255 0.0150
636 DEHYDRATION 1983 0.0149
637 ISCHAEMIC STROKE 265 0.0148
638 FLUID OVERLOAD 216 0.0148
639 ERYTHEMA MULTIFORME 138 0.0148
640 DERMATITIS 310 0.0148
641 HYPOTONIA 147 0.0147
642 IMPAIRED QUALITY OF LIFE 211 0.0147
643 DEAFNESS 383 0.0146
644 EPILEPSY 447 0.0146
645 ACUTE MYOCARDIAL INFARCTION 431 0.0146
646 MOTOR DYSFUNCTION 148 0.0145
647 ASPIRATION 159 0.0145
648 HICCUPS 119 0.0145
649 DEPRESSED LEVEL OF CONSCIOUSNESS 572 0.0144
650 MYOCARDIAL ISCHAEMIA 164 0.0144
651 HAEMORRHOIDS 280 0.0143
652 ORAL PAIN 320 0.0143
653 PHARYNGITIS 177 0.0143
654 DRUG INTOLERANCE 1373 0.0142
655 HEPATITIS C 170 0.0141
656 RESPIRATORY RATE INCREASED 125 0.0141
657 PERITONITIS 290 0.0140
658 WOUND INFECTION 153 0.0140
659 PULMONARY CONGESTION 184 0.0139
660 BLOOD MAGNESIUM DECREASED 120 0.0139
661 CYSTITIS 440 0.0138
662 HAEMOPTYSIS 385 0.0138
663 PLATELET COUNT INCREASED 179 0.0137
664 SKIN ULCER 354 0.0137
665 GLOMERULAR FILTRATION RATE DECREASED 168 0.0137
666 DRUG ERUPTION 242 0.0136
667 LOWER RESPIRATORY TRACT INFECTION 620 0.0136
668 ABDOMINAL PAIN 3160 0.0136
669 BLOOD SODIUM DECREASED 256 0.0136
670 NODULE 177 0.0135
671 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 396 0.0135
672 REBOUND EFFECT 152 0.0134
673 LIVER FUNCTION TEST ABNORMAL 390 0.0134
674 THERAPEUTIC RESPONSE DECREASED 812 0.0134
675 CARDIAC ARREST 1104 0.0134
676 COGNITIVE DISORDER 623 0.0133
677 DELIRIUM 462 0.0133
678 BLOOD COUNT ABNORMAL 200 0.0132
679 DYSPHAGIA 1252 0.0132
680 BLOOD CALCIUM DECREASED 148 0.0131
681 VENTRICULAR EXTRASYSTOLES 136 0.0131
682 HYPERKALAEMIA 459 0.0131
683 DECREASED APPETITE 3036 0.0131
684 ORTHOSTATIC HYPOTENSION 227 0.0130
685 HAEMATEMESIS 330 0.0130
686 DYSPNOEA EXERTIONAL 483 0.0128
687 NEPHROPATHY 119 0.0127
688 EPISTAXIS 949 0.0127
689 ALOPECIA 2475 0.0126
690 ARRHYTHMIA 595 0.0126
691 SPINAL PAIN 147 0.0125
692 MELAENA 273 0.0124
693 VENTRICULAR TACHYCARDIA 203 0.0123
694 FLANK PAIN 115 0.0123
695 BODY TEMPERATURE DECREASED 120 0.0122
696 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 866 0.0122
697 HAEMORRHAGE 1269 0.0121
698 SKIN REACTION 170 0.0121
699 OBESITY 192 0.0120
700 METABOLIC ACIDOSIS 385 0.0120
701 ASTHENIA 4507 0.0120
702 TOOTH ABSCESS 122 0.0120
703 DIARRHOEA 7731 0.0120
704 NAUSEA 9357 0.0118
705 DYSARTHRIA 443 0.0118
706 PRODUCT USE ISSUE 2209 0.0117
707 CONSTIPATION 2561 0.0117
708 VENTRICULAR FIBRILLATION 130 0.0117
709 GASTRITIS 305 0.0116
710 CONFUSIONAL STATE 1864 0.0115
711 SENSORY DISTURBANCE 185 0.0115
712 DYSURIA 424 0.0115
713 PRODUCTIVE COUGH 547 0.0114
714 HYPOTHERMIA 116 0.0114
715 MUSCULOSKELETAL CHEST PAIN 177 0.0114
716 DISORIENTATION 453 0.0114
717 PALLOR 311 0.0114
718 RED BLOOD CELL SEDIMENTATION RATE INCREASED 126 0.0114
719 URINARY TRACT INFECTION 1939 0.0114
720 HYPERTENSION 2403 0.0113
721 OSTEOPENIA 172 0.0113
722 LIVER FUNCTION TEST INCREASED 243 0.0113
723 GASTRIC ULCER 214 0.0112
724 OEDEMA PERIPHERAL 1366 0.0112
725 DIALYSIS 159 0.0112
726 FULL BLOOD COUNT ABNORMAL 118 0.0111
727 PANCREATITIS 589 0.0111
728 GASTRIC HAEMORRHAGE 128 0.0111
729 HEPATIC ENZYME INCREASED 758 0.0111
730 NIGHT SWEATS 358 0.0111
731 SYNCOPE 1111 0.0111
732 INFLAMMATION 565 0.0109
733 CARDIAC FAILURE CONGESTIVE 876 0.0109
734 CONDITION AGGRAVATED 3314 0.0109
735 OXYGEN SATURATION DECREASED 612 0.0109
736 MYOCLONUS 129 0.0108
737 DRUG LEVEL INCREASED 179 0.0108
738 THROMBOSIS 867 0.0108
739 HAEMATOMA 279 0.0108
740 MUSCULAR WEAKNESS 1216 0.0107
741 PARALYSIS 153 0.0107
742 DRUG INEFFECTIVE 14044 0.0106
743 DIPLOPIA 276 0.0106
744 APPLICATION SITE PAIN 234 0.0106
745 NEURALGIA 255 0.0105
746 UNRESPONSIVE TO STIMULI 270 0.0105
747 ULCER 166 0.0104
748 BLOOD POTASSIUM DECREASED 312 0.0104
749 DRUG INTERACTION 1641 0.0103
750 LETHARGY 589 0.0102
751 HYPERLIPIDAEMIA 122 0.0102
752 CARDIO-RESPIRATORY ARREST 424 0.0101
753 DIVERTICULITIS 280 0.0101
754 APPLICATION SITE PRURITUS 229 0.0101
755 URINARY INCONTINENCE 299 0.0101
756 DRUG EXPOSURE DURING PREGNANCY 340 0.0100
757 BONE DISORDER 182 0.0100
758 AMENORRHOEA 175 0.0100
759 URINARY RETENTION 333 0.0100
760 ELECTROCARDIOGRAM QT PROLONGED 358 0.0099
761 STEVENS-JOHNSON SYNDROME 221 0.0099
762 EOSINOPHILIA 174 0.0099
763 INTESTINAL OBSTRUCTION 374 0.0099
764 SKIN DISORDER 330 0.0099
765 FOETAL EXPOSURE DURING PREGNANCY 804 0.0099
766 MATERNAL EXPOSURE DURING PREGNANCY 878 0.0098
767 DEATH 8486 0.0098
768 CONJUNCTIVITIS 182 0.0098
769 COMA 467 0.0098
770 BRADYCARDIA 519 0.0098
771 POST PROCEDURAL COMPLICATION 187 0.0097
772 ANAPHYLACTIC REACTION 538 0.0097
773 PRODUCT PRESCRIBING ISSUE 210 0.0096
774 BLINDNESS 391 0.0096
775 HEPATIC CIRRHOSIS 179 0.0095
776 NEOPLASM MALIGNANT 632 0.0095
777 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 242 0.0094
778 FACE OEDEMA 156 0.0092
779 OSTEOPOROSIS 380 0.0092
780 COUGH 2577 0.0092
781 TOOTH INFECTION 121 0.0092
782 HYPERTHYROIDISM 131 0.0090
783 IMMUNE SYSTEM DISORDER 119 0.0090
784 ILL-DEFINED DISORDER 544 0.0089
785 BRONCHOSPASM 127 0.0089
786 TASTE DISORDER 179 0.0088
787 SARS-COV-2 TEST POSITIVE 116 0.0088
788 DYSPNOEA 4972 0.0088
789 RENAL DISORDER 406 0.0087
790 CYANOSIS 137 0.0087
791 HYPOKINESIA 126 0.0087
792 COLON CANCER 129 0.0086
793 APPLICATION SITE ERYTHEMA 226 0.0086
794 GOUT 151 0.0084
795 FATIGUE 6371 0.0082
796 FEEDING DISORDER 163 0.0080
797 BLOOD PRESSURE DECREASED 529 0.0080
798 RECTAL HAEMORRHAGE 342 0.0080
799 CHEST PAIN 1471 0.0079
800 VISUAL ACUITY REDUCED 262 0.0079
801 RHABDOMYOLYSIS 327 0.0078
802 RASH ERYTHEMATOUS 373 0.0078
803 BLOOD PRESSURE SYSTOLIC INCREASED 150 0.0077
804 BLOOD CREATINE PHOSPHOKINASE INCREASED 218 0.0076
805 EXPOSURE DURING PREGNANCY 469 0.0075
806 ANGINA PECTORIS 216 0.0075
807 BLISTER 422 0.0075
808 WEIGHT DECREASED 2097 0.0075
809 CARDIOVASCULAR DISORDER 190 0.0075
810 RASH PAPULAR 167 0.0074
811 IMPAIRED HEALING 244 0.0074
812 CHOLELITHIASIS 242 0.0074
813 PAIN IN JAW 208 0.0073
814 LACTIC ACIDOSIS 236 0.0073
815 DIABETES MELLITUS 551 0.0072
816 PARAESTHESIA 1132 0.0072
817 CHEST DISCOMFORT 736 0.0072
818 PRESYNCOPE 174 0.0071
819 OROPHARYNGEAL PAIN 654 0.0071
820 SPEECH DISORDER 368 0.0070
821 ABDOMINAL DISTENSION 726 0.0069
822 EAR PAIN 135 0.0069
823 SPINAL FRACTURE 139 0.0069
824 BACK PAIN 1591 0.0068
825 ANAPHYLACTIC SHOCK 176 0.0068
826 RASH 2951 0.0068
827 SINUSITIS 689 0.0067
828 MYALGIA 1142 0.0067
829 ERYTHEMA 1378 0.0067
830 EATING DISORDER 140 0.0066
831 BLOOD TRIGLYCERIDES INCREASED 116 0.0066
832 LACRIMATION INCREASED 198 0.0065
833 HYPOAESTHESIA 976 0.0065
834 CARDIAC DISORDER 608 0.0065
835 SKIN DISCOLOURATION 297 0.0065
836 CATARACT 380 0.0064
837 POLLAKIURIA 265 0.0063
838 LUNG NEOPLASM MALIGNANT 261 0.0063
839 INTERNATIONAL NORMALISED RATIO INCREASED 180 0.0063
840 INFLUENZA 704 0.0063
841 AGITATION 450 0.0061
842 RHINORRHOEA 396 0.0061
843 ADVERSE EVENT 562 0.0061
844 LABORATORY TEST ABNORMAL 179 0.0061
845 HYPOGLYCAEMIA 294 0.0061
846 CHRONIC KIDNEY DISEASE 460 0.0060
847 FAECES DISCOLOURED 131 0.0060
848 HYPERSENSITIVITY 1116 0.0060
849 BRONCHITIS 442 0.0060
850 TRANSIENT ISCHAEMIC ATTACK 201 0.0060
851 DRUG EFFECT INCOMPLETE 215 0.0059
852 MUSCULOSKELETAL PAIN 306 0.0058
853 HALLUCINATION, VISUAL 122 0.0058
854 HAEMATOCHEZIA 317 0.0057
855 RIB FRACTURE 117 0.0057
856 BREAST CANCER 529 0.0057
857 ABDOMINAL PAIN LOWER 143 0.0056
858 SYSTEMIC LUPUS ERYTHEMATOSUS 200 0.0056
859 LOSS OF CONSCIOUSNESS 714 0.0056
860 FLUID RETENTION 281 0.0055
861 SKIN EXFOLIATION 462 0.0055
862 HEADACHE 3404 0.0054
863 PAIN OF SKIN 146 0.0054
864 RASH PRURITIC 293 0.0054
865 RENAL INJURY 160 0.0054
866 CONTRAINDICATED PRODUCT ADMINISTERED 163 0.0054
867 TREMOR 887 0.0053
868 MOVEMENT DISORDER 167 0.0052
869 DISTURBANCE IN ATTENTION 280 0.0052
870 DISCOMFORT 313 0.0051
871 DIABETIC KETOACIDOSIS 123 0.0051
872 MUSCLE TWITCHING 118 0.0051
873 TREATMENT NONCOMPLIANCE 279 0.0051
874 WHEEZING 302 0.0051
875 PSYCHOTIC DISORDER 150 0.0051
876 MENTAL DISORDER 220 0.0051
877 RESPIRATORY ARREST 139 0.0050
878 TINNITUS 230 0.0050
879 RASH GENERALISED 129 0.0050
880 HEART RATE INCREASED 484 0.0049
881 NECK PAIN 271 0.0048
882 HYPOACUSIS 207 0.0048
883 MALAISE 2062 0.0047
884 DYSPEPSIA 459 0.0047
885 SOMNOLENCE 935 0.0046
886 THROAT TIGHTNESS 125 0.0046
887 DYSSTASIA 134 0.0046
888 PAIN 2817 0.0046
889 PAIN IN EXTREMITY 1337 0.0045
890 ABDOMINAL PAIN UPPER 932 0.0045
891 DYSGEUSIA 333 0.0045
892 THERAPY CESSATION 230 0.0045
893 CEREBROVASCULAR ACCIDENT 757 0.0045
894 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 232 0.0044
895 GASTROOESOPHAGEAL REFLUX DISEASE 354 0.0044
896 GAIT DISTURBANCE 831 0.0043
897 DYSPHONIA 251 0.0043
898 SWELLING FACE 274 0.0042
899 ARTHRALGIA 1729 0.0042
900 FALL 1376 0.0041
901 PALPITATIONS 481 0.0041
902 TYPE 2 DIABETES MELLITUS 138 0.0041
903 CORONARY ARTERY DISEASE 124 0.0041
904 HYPERHIDROSIS 526 0.0041
905 INTENTIONAL DOSE OMISSION 116 0.0041
906 SWELLING 367 0.0039
907 HEAD INJURY 124 0.0039
908 MYOCARDIAL INFARCTION 682 0.0039
909 HALLUCINATION 294 0.0039
910 DIZZINESS 1936 0.0039
911 PRURITUS 1465 0.0038
912 RESTLESSNESS 138 0.0038
913 VERTIGO 229 0.0038
914 LIMB DISCOMFORT 116 0.0037
915 ABNORMAL BEHAVIOUR 147 0.0037
916 WEIGHT INCREASED 828 0.0037
917 BALANCE DISORDER 319 0.0037
918 UNEVALUABLE EVENT 277 0.0037
919 VISION BLURRED 501 0.0036
920 MOBILITY DECREASED 261 0.0036
921 SLEEP DISORDER 256 0.0036
922 NASAL CONGESTION 212 0.0036
923 RASH MACULAR 126 0.0036
924 VISUAL IMPAIRMENT 443 0.0036
925 MEMORY IMPAIRMENT 491 0.0036
926 HOSPITALISATION 544 0.0035
927 DRY MOUTH 287 0.0035
928 INFLUENZA LIKE ILLNESS 284 0.0034
929 URTICARIA 574 0.0034
930 NO ADVERSE EVENT 618 0.0034
931 ANGIOEDEMA 150 0.0034
932 CONTUSION 325 0.0034
933 AMNESIA 216 0.0033
934 BLOOD PRESSURE INCREASED 503 0.0033
935 ABDOMINAL DISCOMFORT 550 0.0033
936 DRY EYE 163 0.0033
937 INSOMNIA 867 0.0033
938 DYSKINESIA 132 0.0032
939 ADVERSE DRUG REACTION 290 0.0032
940 HOT FLUSH 243 0.0032
941 DEPRESSION 731 0.0032
942 THERAPY INTERRUPTED 229 0.0032
943 PERIPHERAL SWELLING 492 0.0032
944 BURNING SENSATION 223 0.0032
945 ANXIETY 900 0.0032
946 ARTHROPATHY 174 0.0031
947 PROSTATE CANCER 250 0.0031
948 OSTEOARTHRITIS 131 0.0031
949 DEPRESSED MOOD 163 0.0031
950 ASTHMA 346 0.0031
951 FLUSHING 308 0.0030
952 NEPHROLITHIASIS 138 0.0030
953 SKIN IRRITATION 137 0.0030
954 UNDERDOSE 218 0.0030
955 MUSCLE SPASMS 545 0.0030
956 MEDICATION ERROR 163 0.0029
957 ABORTION SPONTANEOUS 116 0.0029
958 ARTHRITIS 225 0.0029
959 EMOTIONAL DISTRESS 340 0.0028
960 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 134 0.0028
961 MUSCULOSKELETAL STIFFNESS 242 0.0028
962 VAGINAL HAEMORRHAGE 119 0.0027
963 NASOPHARYNGITIS 505 0.0027
964 FLATULENCE 153 0.0027
965 THERAPEUTIC PRODUCT EFFECT DECREASED 120 0.0027
966 FEELING HOT 160 0.0026
967 DRY SKIN 337 0.0025
968 EYE PAIN 142 0.0025
969 ECZEMA 130 0.0025
970 JOINT SWELLING 278 0.0023
971 SURGERY 131 0.0022
972 ILLNESS 229 0.0022
973 BLOOD GLUCOSE INCREASED 411 0.0022
974 BLADDER CANCER 125 0.0021
975 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 373 0.0021
976 IRRITABILITY 123 0.0020
977 SKIN BURNING SENSATION 146 0.0020
978 INJECTION SITE REACTION 129 0.0019
979 OVERDOSE 400 0.0019
980 INJURY 127 0.0018
981 RHEUMATOID ARTHRITIS 197 0.0017
982 FEELING ABNORMAL 407 0.0017
983 INTENTIONAL PRODUCT MISUSE 142 0.0016
984 MIGRAINE 150 0.0016
985 DRUG DOSE OMISSION 158 0.0010
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 177 0.0009
987 PRODUCT DOSE OMISSION ISSUE 251 0.0009
988 INCORRECT DOSE ADMINISTERED 169 0.0007
989 INJECTION SITE PAIN 158 0.0005